FEMPRO (letrozole) is a potent aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. It is also used to induce ovulation in women with fertility issues.
Recommended for:
Postmenopausal women with hormone-positive breast cancer
As adjuvant therapy after surgery
For recurrence prevention
For ovulation induction in infertility treatment
Hormone-dependent breast cancer in postmenopausal women
Adjuvant therapy after surgery
Ovulation induction in women with infertility
FEMPRO is taken orally once daily, preferably at the same time each day. The duration and dose are determined by the treating physician based on the treatment goals and the patient’s individual condition.
Hypersensitivity to letrozole
Premenopausal status (without supportive therapy)
Severe liver impairment
Pregnancy and breastfeeding
Hot flashes, headache
Joint and muscle pain
Fatigue, dizziness
Osteopenia and osteoporosis with long-term use
Vaginal dryness, increased cholesterol levels
